Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285496697> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4285496697 abstract "Introduction: In the scenario of implantology and osteoporosis, it is highlighted that the high need and use of treatments related to dental implants result from the combined effect of several factors, highlighting aging and bone fragility. In this context, osteoporosis is a global bone disease prevalent in human aging. Bisphosphonates (BPs) are commonly used as therapy because they influence hard and soft tissue calcium metabolism. Objective: It was to present the main considerations and scientific evidence of the use of bisphosphonate in the osseointegration process for dental implants in patients with osteoporosis, as well as to emphasize the harm caused by the occurrence of osteonecrosis. Methods: The rules of the Systematic Review-PRISMA Platform were followed. The research was carried out from February 2022 to May 2022 and developed based on Scopus, PubMed, Science Direct, Scielo, and Google Scholar. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. Results and Conclusion: A total of 110 articles were found. In total, 58 articles were fully evaluated and 28 were included and evaluated in this study. Of the initial total of articles, 26 articles were excluded because they did not meet the GRADE classification, and 4 were excluded because they presented a risk of bias. It was concluded that osteoporosis is a metabolic condition that affects alveolar bone density, which may compromise the dental implant process. Therefore, the careful use of bisphosphonates is necessary for the osseointegration process, however, dental surgeons are encouraged to know the diagnosis so that they can make a careful assessment, observing the quality of the bone through routine imaging exams, to prevent osteonecrosis. In addition, alendronate sodium is used to decrease bone resorption, being an adjuvant therapeutic agent for the treatment of osteoporosis." @default.
- W4285496697 created "2022-07-15" @default.
- W4285496697 creator A5051560516 @default.
- W4285496697 creator A5052989122 @default.
- W4285496697 creator A5072688963 @default.
- W4285496697 date "2022-07-12" @default.
- W4285496697 modified "2023-09-26" @default.
- W4285496697 title "Benefits and harmfulness of the use of bisphosphonate in the osseointegration process for dental implants in patients with osteoporosis: a concise systematic review" @default.
- W4285496697 doi "https://doi.org/10.54448/mdnt22s404" @default.
- W4285496697 hasPublicationYear "2022" @default.
- W4285496697 type Work @default.
- W4285496697 citedByCount "0" @default.
- W4285496697 crossrefType "journal-article" @default.
- W4285496697 hasAuthorship W4285496697A5051560516 @default.
- W4285496697 hasAuthorship W4285496697A5052989122 @default.
- W4285496697 hasAuthorship W4285496697A5072688963 @default.
- W4285496697 hasBestOaLocation W42854966971 @default.
- W4285496697 hasConcept C101414908 @default.
- W4285496697 hasConcept C126322002 @default.
- W4285496697 hasConcept C141071460 @default.
- W4285496697 hasConcept C151730666 @default.
- W4285496697 hasConcept C17744445 @default.
- W4285496697 hasConcept C189708586 @default.
- W4285496697 hasConcept C199343813 @default.
- W4285496697 hasConcept C199539241 @default.
- W4285496697 hasConcept C2776541429 @default.
- W4285496697 hasConcept C2777251235 @default.
- W4285496697 hasConcept C2777556957 @default.
- W4285496697 hasConcept C2779134260 @default.
- W4285496697 hasConcept C2779343474 @default.
- W4285496697 hasConcept C2779473830 @default.
- W4285496697 hasConcept C2779921893 @default.
- W4285496697 hasConcept C2780338112 @default.
- W4285496697 hasConcept C2781411149 @default.
- W4285496697 hasConcept C71924100 @default.
- W4285496697 hasConcept C83867959 @default.
- W4285496697 hasConcept C86803240 @default.
- W4285496697 hasConceptScore W4285496697C101414908 @default.
- W4285496697 hasConceptScore W4285496697C126322002 @default.
- W4285496697 hasConceptScore W4285496697C141071460 @default.
- W4285496697 hasConceptScore W4285496697C151730666 @default.
- W4285496697 hasConceptScore W4285496697C17744445 @default.
- W4285496697 hasConceptScore W4285496697C189708586 @default.
- W4285496697 hasConceptScore W4285496697C199343813 @default.
- W4285496697 hasConceptScore W4285496697C199539241 @default.
- W4285496697 hasConceptScore W4285496697C2776541429 @default.
- W4285496697 hasConceptScore W4285496697C2777251235 @default.
- W4285496697 hasConceptScore W4285496697C2777556957 @default.
- W4285496697 hasConceptScore W4285496697C2779134260 @default.
- W4285496697 hasConceptScore W4285496697C2779343474 @default.
- W4285496697 hasConceptScore W4285496697C2779473830 @default.
- W4285496697 hasConceptScore W4285496697C2779921893 @default.
- W4285496697 hasConceptScore W4285496697C2780338112 @default.
- W4285496697 hasConceptScore W4285496697C2781411149 @default.
- W4285496697 hasConceptScore W4285496697C71924100 @default.
- W4285496697 hasConceptScore W4285496697C83867959 @default.
- W4285496697 hasConceptScore W4285496697C86803240 @default.
- W4285496697 hasIssue "S4" @default.
- W4285496697 hasLocation W42854966971 @default.
- W4285496697 hasOpenAccess W4285496697 @default.
- W4285496697 hasPrimaryLocation W42854966971 @default.
- W4285496697 hasRelatedWork W2122846005 @default.
- W4285496697 hasRelatedWork W2213664750 @default.
- W4285496697 hasRelatedWork W2339710741 @default.
- W4285496697 hasRelatedWork W2347233032 @default.
- W4285496697 hasRelatedWork W2353286404 @default.
- W4285496697 hasRelatedWork W2589424220 @default.
- W4285496697 hasRelatedWork W2908578951 @default.
- W4285496697 hasRelatedWork W4323310030 @default.
- W4285496697 hasRelatedWork W4366181057 @default.
- W4285496697 hasRelatedWork W4366214509 @default.
- W4285496697 hasVolume "3" @default.
- W4285496697 isParatext "false" @default.
- W4285496697 isRetracted "false" @default.
- W4285496697 workType "article" @default.